Experimental validation of metabolic pathway modeling.

Understanding how metabolic pathways function in parasites is crucial for identifying potential drug targets. Prior research has shown that glycolysis in Entamoeba histolytica involves multiple enzymes that may control flux in different ways. However, no prior work had resolved how these enzymes interact in a complete pathway under physiological conditions. This gap motivated the use of both experimental and computational methods to study flux control. It was already known that metabolic control analysis could predict enzyme behavior, but these predictions had not been validated experimentally in this context. That uncertainty drove the current study to reconstitute glycolytic segments in vitro and compare them with models. No prior work had resolved how metabolite interactions affect flux control in these pathways. This gap motivated the integration of enzyme kinetics with pathway modeling. It was already known that enzyme inhibitors could alter flux, but their combined effects in a pathway were not well understood.

The aim of this study was to experimentally determine how flux control is distributed among enzymes in the glycolytic pathway of Entamoeba histolytica. The specific problem addressed was the discrepancy between modeled predictions and experimental observations of flux control. The motivation was to identify the reasons for this discrepancy and refine the model accordingly. The researchers proposed that incorporating previously overlooked enzyme interactions would improve model accuracy. The study focused on two glycolytic segments: the first and final parts of the pathway. The goal was to compare in vitro reconstitution with computational modeling. The researchers proposed that this comparison could reveal missing kinetic interactions. The specific question was whether revised rate equations could align model predictions with experimental results.

The first and final glycolytic segments were reconstituted in vitro using recombinant enzymes. The reconstitution included hexokinase, hexose-6-phosphate isomerase, PP(i)-PFK, aldolase, triose-phosphate isomerase, 3-phosphoglycerate mutase, enolase, and pyruvate phosphate dikinase. Experiments were conducted under near-physiological pH, temperature, and enzyme proportions. Flux control was determined by titrating flux with each enzyme component. In parallel, both segments were modeled using rate equations and kinetic parameters from prior studies. The researchers proposed that discrepancies between models and experiments indicated missing interactions. Kinetic interactions among reconstituted components were experimentally revised. The revised models incorporated new inhibitor effects and enzyme activity changes.

The experimentally determined flux control distribution did not match the modeled predictions. This discrepancy led to revised experiments that identified new kinetic interactions. For the final segment, 3-phosphoglycerate was found to be a weakly competitive inhibitor of enolase. PP(i) was a moderate inhibitor of 3-phosphoglycerate mutase and enolase. For the first segment, PP(i) was a strong inhibitor of aldolase and a nonessential mixed-type activator of hexokinase. Lower V(max) values were observed for hexose-6-phosphate isomerase, PP(i)-PFK, and aldolase due to PP(i) or ATP inhibition. These modifications in rate equations allowed models to predict flux control similar to experimental results. The revised models also predicted flux rates and metabolite concentrations matching experimental data.

The combination of in vitro pathway reconstitution with modeling and enzyme kinetics experimentation improved understanding of glycolytic control in Entamoeba histolytica. The researchers proposed that this approach reveals interactions missed in earlier models. The study found that PP(i) and ATP inhibition significantly affect enzyme activity. The revised models predicted flux control by 3-phosphoglycerate mutase and hexokinase under physiological conditions. The results suggested that parallel routes have a nonsignificant effect on flux rate. The researchers proposed that this is due to the low activity of alternative enzymes in the ameba. The validated models allowed in silico experimentation, which is difficult in in vivo or in vitro systems. The authors concluded that integrating experimental and computational methods provides a more comprehensive view of pathway behavior.